It is a pharma private limited company based in Ahmedabad, Gujarat, India, established in 2013.
2013 | Ahmedabad, Gujarat, India | ActiveUnimedia Pharmaceuticals Private Limited, a active private limited company, was established on 21 March 2013 in Ahmedabad, Gujarat, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24233GJ2013PTC074110. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.50 M.
Formerly known as Aqsa Remedies Private Limited. It upholds a compliant status. Its leadership includes Mohammadzahid Abdulrashid Mall (Director), Abdulrashid Abdulmajid Mall (Director). It holds ₹6.06 M open charges and no settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Plot 1706, Phase Iii, Gidc Vatva, Ahmedabad, Gujarat, 382445.
U24233GJ2013PTC074110
074110
21 March 2013
₹0.50 M
₹0.50 M
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Unimedia Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Mohammadzahid Abdulrashid Mall | Director | 21 Mar 2013 | Current |
| Abdulrashid Abdulmajid Mall | Director | 21 Mar 2013 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Unimedia Pharmaceuticals Private Limited, for the financial year ended 2024, experienced modest growth in revenue, with a 5.49% increase. The company also saw a substantial improvement in profitability, with a 134.63% increase in profit. The company's net worth Soared by an impressive increase of 17.18%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Unimedia Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹6,060,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 07 Nov 2023 | Others | ₹0.93 M | Open |
| 15 Nov 2019 | Others | ₹0.90 M | Open |
| 18 Nov 2013 | Others | ₹4.23 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Unimedia Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Unimedia Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Unimedia Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Unimedia Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.
The activity Unimedia Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad. was completed.
Progress on A charge with Others amounted to Rs. 0.93 M with Charge ID 100836944 was registered on 07 Nov 2023. was documented.
The activity A charge with Others of Rs. 4.23 M registered on 18 Nov 2013 with Charge ID 10466940 was modified on 14 Jul 2020. was completed.
A charge with Others amounted to Rs. 0.90 M with Charge ID 100320020 was registered on 15 Nov 2019. was recorded as a recent event.
Progress on A charge with Others amounted to Rs. 4.23 M with Charge ID 10466940 was registered on 18 Nov 2013. was documented.
The CIN of Unimedia Pharmaceuticals Private Limited is U24233GJ2013PTC074110.
Unimedia Pharmaceuticals Private Limited is headquartered at Plot 1706, Phase Iii, Gidc Vatva, Ahmedabad, Gujarat, 382445.
Unimedia Pharmaceuticals Private Limited was incorporated on 21 March 2013.
The current directors of Unimedia Pharmaceuticals Private Limited are
The primary industry of Unimedia Pharmaceuticals Private Limited is Manufacturing.
Unimedia Pharmaceuticals Private Limited is unlisted.
The authorized capital of Unimedia Pharmaceuticals Private Limited is ₹0.50 M, and the paid-up capital is ₹0.50 M.
The compliance status of Unimedia Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX